None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women aged 25 to 70 years 2) People who signed the informed consent form before participating in the study 3) Healthy people whose peripheral blood WBC count = 4X1000 and < 8X1000 cells/ul at screening
Exclusion criteria
Exclusion criteria: 1) subjects with clinically significant cardiovascular, immune, infectious, or neoplastic disease currently 2) subjects with a known history of myocardial infarction or cerebrovascular disease within the last 6 months 3) subjects who are under treatment for uncontrolled hypertension, diabetes, thyroid disease etc. (However, subjects can be involved in the study based on doctor’s assessment) 4) subjects whose AST(GOT) or ALT(GPT) level is more than three times higher than the upper limit of the normal range 5) subjects whose creatinine level is more than twice higher than the upper limit of the normal range 6) subjects who have regularly taken functional foods or drugs within the last 3 months or suffered from infection within the last 3 months prior to the first visit of the study 7) subjects who are pregnant or scheduled for pregnancy 8) subjects with a serious mental illness 9) subjects who are scheduled for another study during this study period 10) subjects with any other health concerns
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NK cell activity;WBC count;IFN-?;IL-2, 4, 10, 12;TNF-a | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse events ;clinical pathological tests (hematologic test, blood chemical test, urine test), ;vital sign (blood pressure, pulse) | — |
Countries
Korea, Republic of
Contacts
Hanyang University